Ruzanna Papyan: Our abstract on Anti-GD2 for Neuroblastoma will be an oral presentation at SIOP
Ruzanna Papyan shared on LinkedIn:
“Week 4 of the Global Access To Anti GD2 Campaign
This week, I am thrilled to share some exciting news about our progress and achievements in advocating for global access to anti-GD2 therapies.
I am honored to announce that our abstract titled ‘Assessing Global Accessibility and Affordability of Anti-GD2 Monoclonal Antibodies for Neuroblastoma Treatment: A Survey-Based Study’ has been selected for an oral presentation at the Annual Congress of the International Society of Pediatric Oncology (SIOP), held in Honolulu, Hawaii, USA, from October 17 – 20, 2024.
Additionally, I have been awarded the prestigious SIOP Young Investigator Award for this work! This recognition underscores the importance of our research and the impact it has on the pediatric oncology community.
Our study surveyed 33 centers across 27 countries, revealing significant disparities in the availability and affordability of anti-GD2 therapies for treating high-risk neuroblastoma. Despite advances in treatment, the high cost of anti-GD2 monoclonal antibodies remains a barrier, especially in low- and middle-income countries.
By advocating for the inclusion of anti-GD2 therapies in the World Health Organization Essential Medicines List, we can help make these life-saving treatments accessible to children worldwide.
Join us in our mission to enhance global access to these critical therapies. Your support, knowledge sharing, and advocacy are key to changing lives.
Let’s give every child the future they deserve.
Apart from that make sure to mark your calendars and join us in Honolulu.”
Source: Ruzanna Papyan/LinkedIn
Ruzanna Papyan is a pediatric oncologist and clinical research physician at the Pediatric Cancer and Blood Disorders Center of Armenia, Hematology Center after Prof. Yeolyan. She is also Head of the Musculoskeletal Multidisciplinary Working Group and Assistant Professor at the Department of Pediatric Oncology and Hematology at Yerevan State Medical University.
Dr. Papyan coordinates educational sessions for the Global Neuroblastoma Network and holds the esteemed position of co-chair of the Adolescents and Young Adults Steering Group at the International Society of Paediatric Oncology (SIOP). She is a member of oncology societies, such as AAHO, SOHO, ESMO, ESO, and POEM. Her research interests include soft tissue and bone sarcomas, and neuroblastomas among children and young adults.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023